Allison et al., 1996, “Antibody dependent cell-mediated cytotoxicity (ADCC) of an anti-HER2 antibody requires opsonization of tumor target”, FASEB Abstract/Poster. |
Bolland et al., 1998, “SHIP modulates immune receptor responses by regulating membrane association of Btk”, Immunity 8:509-516. |
Carter et al., 1992, “Humanization of an anti-p185HER2 antibody for human cancer therapy”, Proc. Natl. Acad. Sci. USA 89:4285-4289. |
Clynes et al., 1998, “Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis”, Science 279:1052-1054. |
Clynes et al., 1998, “Fc receptors are required in passive and active immunity to melanoma”, Proc. Natl. Acad. Sci. USA 95:652-656. |
Clynes ey al., 1999, “Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors”, J. Exp. Med. 189:179-185. |
Clynes and Ravetch, 1995, “Cytotoxic antibodies trigger inflammation through Fc receptors”, Immunity 3:21-26. |
Diamond and Yelton, 1981, “A new Fc receptor on mouse macrophages binding IgG3 ”, J. Exp. Med. 153:514-519. |
Hara et al., 1995, “Implicating a role for immune recognition of self in tumor rejection: passive immunization against the Brown locus protein”, J. Exp. Med. 182:1609-1614. |
Hazenbos, 1996, Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII(CD16) deficient mice, Immunity 5:181-188. |
Heiken et al., 1996, “T lymphocyte development in the absence of Fcε receptor Iγ subunit: analysis of thymic-dependent and independent αβ and γδ pathways”, Eur. J. Immunol. 26:1935-1943. |
Hotaling et al., 1996, “The humanized anti-HER2 antibody rhuMAb HER2 mediates antibody dependent cell -mediated cytotoxicity via FcγR III”, AACR Abstract/Poster. |
Houghton, 1994, “Cancer antigens: immune recognition of self and altered self”, J. Exp. Med. 180:1-4. |
Jaffe and Perdoll, 1996, “Murine tumor antigens: is it worth the search?”, Curr. Opin. Immunol. 8:622-627. |
Li et al., 1996, “Reconstitution of human FcγRIII cell type specificity in transgenic mice”, J. Exp. Med. 183:1259-1263. |
Naftzger et al., 1996, “Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity”, Proc. Natl. Acad. Sci. USA 93:14809-14814. |
Okada et al., 1998, “Cutting edge: role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response”, J. Immunol. 161:5129-5132. |
Ono et al., 1996, “Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB”, Nature 383:263-266. |
Ono et al., 1997, “Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling”, Cell 90:293-301. |
Presta et al., 1994, “The binding site on human immunoglobulin E for its high affinity receptor”, J. Biol. Chem. 269:26368-26373. |
Ravetch and Clynes, 1998, “Divergent roles for Fc receptors and complement in vivo”,Ann. Rev. Immunol. 16:421-432. |
Ravetch, 1994, “Fc receptors: Rubor redux”, Cell 78:553-560. |
Ravetch, 1997, “Fc receptors”, Curr. Opin. Immunol. 9:121-125. |
Shores et al., 1998, “T cell development in mice lacking all T cell receptor ζ family members (ζ, η, and FcεRlγ)”, J. Exp. Med. 187:1093-1101. |
Suzuki et al., 1998, “Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti GBM glomerulonephritis”, Kidney Int. 54:1166-1174. |
Sylvestre et al., 1996, “Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice”, J. Exp. Med. 184:2385-2392. |
Sylvestre and Ravetch, 1996, “A dominant role for Mast cell Fc receptors in the Arthus reaction”, Immunity 5:387-309. |
Sylvestre and Ravetch, 1994, “Rc receptors initiate the Arthus reaction: redefining the inflammatory cascade”, Science 265:1095-1098. |
Takai et al., 1994, “FcR γ chain deletion results in Pleiotrophic effector cell defects”, Cell 76:519-529. |
Takai et al., 1996, “Augmented humoral and anaphylactic responses in FcγRII-deficient mice”, Nature 379:346-349. |
Takechi et al., 1996, “A melamosmal membrane protein is a cell surface target for melanoma therapy”, Clin. Cancer Res. 2:1837-1842. |
Yuan et al., 1998, “Antibody-mediated modulation of Cryptococcus neoformans infections is dependent on distinct Fc receptor functions and IgG subclasses”, J. Exp. Med. 187:641-648. |